The PTPRC gene helps white blood cells receive and fine tune signals, especially in T cells and B cells that fight infection. Your body relies on this gene to keep immune responses balanced and working when germs need to be cleared. If it does not work properly, the immune system may respond weakly or in an unbalanced way, which can lead to repeated infections and, in some people, autoimmunity. PTPRC is also known as CD45, a marker doctors often use to identify blood and immune cells.

What is a gene?

Genes are stretches of DNA that give cells instructions for making molecules or directing processes in the body. Some carry the information needed to make proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.

Overview

PTPRC

Gene function

What if the gene works

The PTPRC gene helps white blood cells send and fine tune signals. This supports normal immune responses, including how T cells and B cells recognize germs and coordinate defense.

Risk

What if the gene does not work

Changes in the PTPRC gene can weaken CD45, a protein that helps white blood cells communicate. More severe variants can lead to a rare immune deficiency with frequent infections, while milder variants may cause subtler immune problems.

Treatment

What does that mean for your treatment

No treatment or drug choice is currently guided specifically by a pathogenic variant in the PTPRC gene in routine clinical guidelines. The PTPRC gene, also called CD45, is being studied as a biomarker and treatment target in some blood cancers and in transplant conditioning.

Conditions associated with PTPRC

T-b+ severe combined immunodeficiency due to cd45 deficiencyT-b+ severe combined immunodeficiency due to il-7ralpha deficiency

Gene function

What if the gene works

White blood cells need clear signals to decide when to respond, rest, or mature. The PTPRC gene supports this day to day control by helping immune cells pass messages in a measured way. Understanding PTPRC gene function is easier if you picture it as part of the cell's signal tuning system for T cells, B cells, and other white blood cells.

Signal control

The PTPRC gene helps white blood cells fine tune incoming signals. Its protein, called CD45, removes small phosphate tags from signaling proteins so immune messages start and stop at the right level.

T cell signaling

In T cells, the PTPRC gene helps set the threshold for when a signal is strong enough to act on. This lets T cells respond in a more controlled way when they recognize a threat.

B cell signaling

In B cells, this gene supports the signaling steps that follow contact with a germ or vaccine target. That steady signaling helps B cells take part in normal antibody responses.

Cell maturation

The PTPRC gene supports the normal development and maturation of several white blood cell types. By guiding signal strength during growth, it helps immune cells become ready for their usual jobs.

What is a variant?

A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and help explain normal variation among people, such as appearance, metabolism, and the way the body responds to environmental influences. Many do not cause any noticeable effect and are simply part of natural genetic diversity. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Variants in the PTPRC gene can change how much CD45 reaches the surface of immune cells or how well it sends signals inside the cell. Milder variants may alter RNA splicing (how the cell edits the gene message), changing the mix of CD45 forms, while more severe loss-of-function variants can greatly reduce or fully remove CD45 activity. This helps explain how PTPRC gene variants affect protein function and why stronger variants are linked to earlier and more marked immune deficiency.

How variants are linked to conditions

Rare pathogenic variants in the PTPRC gene are linked to CD45 deficiency, a rare inherited immune condition often classified as severe combined immunodeficiency. People with this condition often have frequent or unusual infections early in life, and finding disease-causing variants in both copies of the PTPRC gene can confirm the diagnosis. Some PTPRC variants have also been studied in autoimmune diseases, but those links are not as firmly established.

A variant is not necessarily a diagnosis

DNA variants are a routine part of being human and are common throughout the general population. Most have no direct impact on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences also play a role. In some instances, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PTPRC gene. If you have a change in PTPRC or a family history of immune system problems, a doctor or genetic counselor can help explain what that may mean for your personal risk.

Inheritance of PTPRC variants

PTPRC-related conditions that are clearly linked to inherited gene changes are generally passed down in an autosomal recessive pattern. In practical terms, how PTPRC gene variants are inherited usually means a person must receive one altered copy from each parent to be affected. Parents who each carry one PTPRC variant are typically unaffected themselves, and with each pregnancy there is a 25% chance their child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy.

What does my PTPRC result mean for my family?

For families with a disease-causing PTPRC result, the pattern is usually recessive, which means close relatives may also be carriers even if they are healthy. Brothers or sisters could also be affected or carry the same change. This can matter for future pregnancies and for relatives who want to understand their own carrier status.


Genetic information


Genetic testing

How you find out about variants

Genetic testing for PTPRC variants usually uses a blood or saliva sample, and a lab reads the DNA code in the PTPRC gene to look for changes. Testing may be done as part of a larger immune gene panel, whole exome sequencing, or targeted analysis when there is a strong reason to check this specific gene.

When should I consider getting a genetic test?

Consider testing for changes in the PTPRC gene if a baby or child has unusually frequent, severe, or hard-to-treat infections, or there is a family history of a serious inherited immune condition. In this setting, testing can help confirm a rare problem with how the immune system works.

A genetic result is only one part of your health story

A genetic result can be informative, but what it can tell you varies based on the condition and the type of variant involved. Many factors also shape how the body works over time, including age, environment, lifestyle, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at the target tissue. This helps explain why the same medication works well for one person, seems less effective for another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, kidney and liver function, other medicines, and overall health.

What is Pharmacogenetics?

Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It looks at the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. For a more detailed look at this topic, more information is available in the LearnHub.


Drugs influenced by the PTPRC gene

There are 0 Drugs associated with PTPRC
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about side effects, a medicine not working as expected, or how your treatment fits with your overall health, it is a good time to speak with your doctor or pharmacist.

History

PTPRC entered medical research through studies of white blood cells, where scientists identified a surface marker later known as CD45 or the leukocyte common antigen. In the late 1970s and 1980s, this marker became an important tool for sorting blood and immune cells in both research labs and hospital pathology. Initially understood only through visible traits, later recognized as tied to a specific gene, it was eventually mapped and named the PTPRC gene. This work helped standardize how immune cells were classified, especially in leukemia and lymphoma testing. Over time, descriptions became more precise, and PTPRC became a familiar reference point in immunology and blood cancer diagnostics.

Literature

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved